Global Fungal Infections Market accounted for US$ 1.98 billion in 2020 and is estimated to be US$ 2.52 billion by 2030 and is anticipated to register a CAGR of 3.0%.Pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others is known as an antifungal medicine, sometimes known as an antimycotic medication. The majority of these medications require a doctor's prescription, although a handful are available over the counter (OTC). Antifungals are divided into two categories: local and systemic. Depending on the problem being treated, local antifungals are commonly used topically or vaginally. Antifungals for the system are taken orally or intravenously. Only a few azole antifungals are utilised systemically in clinical practise.

The report " Global Fungal Infections Market, By Drug Type (Echinocandins {Caspofungin, Micafungin, Anidulafungin, and Others}, Azoles {Imidazoles, Voricanazole, Thiazoles, and Others}, Polyenes {Amphotericin B, Candicidin, Hamycin, Natamycin, and Others}, Allylamines {Butenafine, Terbinafine, and Naftifine}, and Others), By Infection Type (Superficial Antifungal Infection and Systemic Antifungal Infection), By Dosage form (Drugs, Ointment, Powder, and Others), By Therapeutic Indication (Aspergillosis, Dermatophytosis, Candidiasis, and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Key Highlights:

In 2021, Posaconazole, a novel triazole antifungal medicine from Cadila Pharmaceuticals, is effective against a wide spectrum of invasive fungal illnesses. The medicine has also been suggested as a second-line treatment for Mucormycosis, also known as black fungus.
In 2021, Posaconazole API was launched by Bajaj Healthcare to treat Mucormycosis (black fungus) infection in COVID-19 patients.
Analyst View:

The rising occurrence of fungal diseases around the world is fueling the market's expansion. Furthermore, increased use of immunosuppressive and antineoplastic drugs, prosthetic devices and grafts, and broad-spectrum antibiotics has led in an upsurge in fungal infections in recent years. According to statistics provided by the Centers for Disease Control and Prevention in 2017, over 220,000 new people are infected with cryptococcal meningitis each year, which is a brain infection that causes 181,000 deaths each year around the world. Because of the high incidence of HIV/AIDS in Sub-Saharan Africa, the majority of the deaths were reported there. Due to the significant prevalence of mycological diseases over the world, this indicates a potential market for antifungal medications. The expansion in the global geriatric population is projected to increase demand for antifungals to treat opportunistic fungal infections, as older people are more susceptible to infectious diseases and chronic disorders, such as HIV and cancer. The demand for fungistatic drugs is expected to continue robust through 2025, owing to an increase in cases of difficult-to-diagnose fungal infections that result in high mortality and morbidity rates.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Fungal Infections Market, By Drug Type (Echinocandins {Caspofungin, Micafungin, Anidulafungin, and Others}, Azoles {Imidazoles, Voricanazole, Thiazoles, and Others}, Polyenes {Amphotericin B, Candicidin, Hamycin, Natamycin, and Others}, Allylamines {Butenafine, Terbinafine, and Naftifine}, and Others), By Infection Type (Superficial Antifungal Infection and Systemic Antifungal Infection), By Dosage form (Drugs, Ointment, Powder, and Others), By Therapeutic Indication (Aspergillosis, Dermatophytosis, Candidiasis, and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”
To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Fungal-Infections-Market-4768

Key Market Insights from the report:

The Global Fungal Infections Market accounted for US$ 1.98 billion in 2020 and is estimated to be US$ 2.52 billion by 2030 and is anticipated to register a CAGR of 3.0%. Global Fungal Infections Market is segmented based on drug type, infection type, dosage form, therapeutic type and region.

Based on Drug Type, Global Fungal Infections Market is segmented into Echinocandins {Caspofungin, Micafungin, Anidulafungin, and Others}, Azoles {Imidazoles, Voricanazole, Thiazoles, and Others}, Polyenes {Amphotericin B, Candicidin, Hamycin, Natamycin, and Others}, Allylamines {Butenafine, Terbinafine, and Naftifine}, and Others.
Based on Infection Type, Global Fungal Infections Market is segmented into Superficial Antifungal Infection and Systemic Antifungal Infection.
Based on Dosage Form, Global Fungal Infections Market is segmented into Drugs, Ointment, Powder, and Others.
Based on Therapeutic Indication, Global Fungal Infections Market is segmented into Aspergillosis, Dermatophytosis, Candidiasis, and Others.
By Region, the Global Fungal Infections Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Competitive Landscape & their strategies of Global Fungal Infections Market:

Some of the market players are Abbott Laboratories, Bayer AG, Astellas Pharma Inc., Glenmark, GlaxoSmithKline PLC, Merck & Co. Inc., Novartis AG, Pfizer Inc, etc.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period
To know more

Contact Us:

Sales

Prophecy Market Insights

1 860 531 2701

Email- [email protected]

Website- www.prophecymarketinsights.com